NICE Seeks Faster PMOS Diagnosis for 1 in 8 Women, Urges Annual UK Checks
Updated
Updated · inews · Jul 3
NICE Seeks Faster PMOS Diagnosis for 1 in 8 Women, Urges Annual UK Checks
3 articles · Updated · inews · Jul 3
Summary
Draft NICE guidance calls for quicker diagnosis and annual reviews for PMOS, saying the condition affects about 1 in 8 women yet remains underdiagnosed and poorly managed in the UK.
Symptoms can include irregular or absent periods, infertility, excess hair and weight gain, while weak management can raise long-term risks such as diabetes and pregnancy complications.
Yasmin Gharbi, 32, said NHS delays and limited support pushed her to seek treatment in Belgium, costing about £5,000 over five years after facing a year-long gynaecology wait.
Emily Mee, 29, said she was twice dismissed in A&E before private care confirmed a ruptured ovarian cyst linked to PMOS, echoing wider complaints that younger women are not taken seriously.
The draft guidance lands amid broader criticism of women's healthcare, with consultants citing long gynaecology waits and a parliamentary report 18 months ago warning that women were being told to simply endure worsening pain.
Could off-label weight-loss drugs soon become the standard NHS treatment for PMOS, despite current guidelines?
Why won't the NHS fund a £100m treatment for a key PMOS symptom if it severely impacts mental health?
Major Overhaul in PMOS (Formerly PCOS) Care: What the 2026 NICE Guidelines Mean for Patients and the NHS
Overview
The new draft guidelines from NICE, published in July 2026, mark a major shift in the diagnosis and treatment of Polyendocrine Metabolic Ovarian Syndrome (PMOS) across the UK. By introducing a simple annual review for those with PMOS, the guidelines aim to standardize care, improve consistency, and boost awareness of the condition. This proactive approach supports earlier diagnosis and better management, addressing both immediate symptoms and long-term health risks. The emphasis on regular monitoring and early intervention is expected to improve patient outcomes and ensure more equitable, effective care nationwide.